Gentera. de Valuation
Is GENTERA * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of GENTERA * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: GENTERA * (MX$26.75) is trading below our estimate of fair value (MX$28.08)
Significantly Below Fair Value: GENTERA * is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for GENTERA *?
Other financial metrics that can be useful for relative valuation.
| What is GENTERA *'s n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | Mex$42.24b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | 0.6x |
Price to Earnings Ratio vs Peers
How does GENTERA *'s PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 19.8x | ||
FINDEP * Financiera Independencia. de SOFOM E.N.R | 4.5x | n/a | Mex$3.2b |
GBM O Corporativo GBM. de | 51.6x | n/a | Mex$22.0b |
GPROFUT * Grupo Profuturo. de | 10.7x | n/a | Mex$28.2b |
INVEX A INVEX Controladora. de | 12.2x | n/a | Mex$12.7b |
GENTERA * Gentera. de | 8.9x | 15.9% | Mex$42.2b |
Price-To-Earnings vs Peers: GENTERA * is good value based on its Price-To-Earnings Ratio (8.9x) compared to the peer average (19.8x).
Price to Earnings Ratio vs Industry
How does GENTERA *'s PE Ratio compare vs other companies in the Global Consumer Finance Industry?
Price-To-Earnings vs Industry: GENTERA * is good value based on its Price-To-Earnings Ratio (8.9x) compared to the Global Consumer Finance industry average (13.1x).
Price to Earnings Ratio vs Fair Ratio
What is GENTERA *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 8.9x |
| Fair PE Ratio | 11.9x |
Price-To-Earnings vs Fair Ratio: GENTERA * is good value based on its Price-To-Earnings Ratio (8.9x) compared to the estimated Fair Price-To-Earnings Ratio (11.9x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | Mex$26.75 | Mex$31.52 +17.8% | 8.2% | Mex$36.00 | Mex$27.00 | n/a | 13 |
| Apr ’25 | Mex$27.72 | Mex$29.79 +7.5% | 10.5% | Mex$36.00 | Mex$24.00 | n/a | 14 |
| Mar ’25 | Mex$25.42 | Mex$29.00 +14.1% | 9.7% | Mex$33.00 | Mex$24.00 | n/a | 13 |
| Feb ’25 | Mex$23.32 | Mex$28.18 +20.9% | 10.0% | Mex$32.90 | Mex$24.00 | n/a | 12 |
| Jan ’25 | Mex$23.58 | Mex$27.43 +16.3% | 10.0% | Mex$32.90 | Mex$24.00 | n/a | 12 |
| Dec ’24 | Mex$20.65 | Mex$26.87 +30.1% | 9.0% | Mex$30.10 | Mex$22.00 | n/a | 12 |
| Nov ’24 | Mex$19.45 | Mex$27.12 +39.4% | 9.1% | Mex$30.10 | Mex$22.00 | n/a | 12 |
| Oct ’24 | Mex$20.46 | Mex$26.57 +29.9% | 9.0% | Mex$30.00 | Mex$22.00 | n/a | 13 |
| Sep ’24 | Mex$21.03 | Mex$26.31 +25.1% | 9.6% | Mex$30.00 | Mex$21.00 | n/a | 14 |
| Aug ’24 | Mex$20.62 | Mex$26.42 +28.1% | 9.9% | Mex$30.00 | Mex$21.00 | n/a | 13 |
| Jul ’24 | Mex$18.35 | Mex$25.89 +41.1% | 9.2% | Mex$30.00 | Mex$21.00 | n/a | 14 |
| Jun ’24 | Mex$18.48 | Mex$26.17 +41.6% | 7.6% | Mex$30.00 | Mex$24.00 | n/a | 14 |
| May ’24 | Mex$19.78 | Mex$26.17 +32.3% | 7.7% | Mex$30.00 | Mex$23.00 | n/a | 14 |
| Apr ’24 | Mex$19.76 | Mex$26.26 +32.9% | 8.5% | Mex$30.00 | Mex$22.00 | Mex$27.72 | 13 |
| Mar ’24 | Mex$19.41 | Mex$26.31 +35.6% | 8.6% | Mex$30.00 | Mex$22.00 | Mex$25.42 | 14 |
| Feb ’24 | Mex$22.83 | Mex$26.10 +14.3% | 10.1% | Mex$31.00 | Mex$22.00 | Mex$23.32 | 14 |
| Jan ’24 | Mex$21.94 | Mex$25.31 +15.4% | 10.9% | Mex$31.00 | Mex$20.00 | Mex$23.58 | 14 |
| Dec ’23 | Mex$20.47 | Mex$24.26 +18.5% | 13.1% | Mex$31.00 | Mex$16.50 | Mex$20.65 | 15 |
| Nov ’23 | Mex$20.49 | Mex$23.79 +16.1% | 13.8% | Mex$31.00 | Mex$16.50 | Mex$19.45 | 15 |
| Oct ’23 | Mex$17.37 | Mex$22.54 +29.8% | 11.7% | Mex$28.00 | Mex$16.50 | Mex$20.46 | 15 |
| Sep ’23 | Mex$15.60 | Mex$21.82 +39.9% | 13.3% | Mex$28.00 | Mex$16.50 | Mex$21.03 | 15 |
| Aug ’23 | Mex$16.95 | Mex$21.09 +24.4% | 11.6% | Mex$25.00 | Mex$16.50 | Mex$20.62 | 15 |
| Jul ’23 | Mex$16.07 | Mex$20.55 +27.9% | 11.1% | Mex$25.00 | Mex$16.50 | Mex$18.35 | 15 |
| Jun ’23 | Mex$14.83 | Mex$20.11 +35.6% | 9.0% | Mex$23.00 | Mex$16.50 | Mex$18.48 | 15 |
| May ’23 | Mex$15.85 | Mex$19.61 +23.7% | 10.9% | Mex$22.00 | Mex$15.00 | Mex$19.78 | 15 |
| Apr ’23 | Mex$16.92 | Mex$18.25 +7.9% | 16.1% | Mex$22.00 | Mex$11.00 | Mex$19.76 | 15 |
Analyst Forecast: Target price is less than 20% higher than the current share price.